New kidney tissue model could help assess safety of immunotherapy drugs

A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.

Related Keywords

Boston ,Massachusetts ,United States ,Munich ,Bayern ,Germany ,Switzerland ,Ken Hiratsuka ,Virginie Micallef ,Alejandro Carpy ,Antje Christine Walz ,Jennifer Lewi ,Joseph Bonventre ,Donald Ingber ,Kimberly Homan ,Mariana Mata ,Jennifer Lewis ,Marcel Gruber ,Annie Moisan ,Ryuji Morizane ,Katharina Kroll ,Lily Ramsey ,Genentech ,National Center ,International Foundation Of Ethical Research ,Drug Administration ,Harvard Johna Paulson School Of Engineering ,Wyss Institute ,Harvard Medical School ,Roche Innovation Center Basel ,D Organ Engineering Initiative ,Roche Innovation Centers ,Roche Pharma Research Early Development ,Roche Innovation Centers In Basel ,Biologically Inspired Engineering ,Harvard University ,Harvard John ,Applied Sciences ,Wilm Tumor ,Wyss Core Faculty ,Wyss Professor ,Morgan Engineering ,Postdoctoral Fellow ,Wyss Founding Director Donald Ingber ,Judah Folkman Professor ,Vascular Biology ,Boston Children ,Bioinspired Engineering ,Estelle Marrer Berger ,Roche Pharma Research ,Early Development ,Advancing Translational ,International Foundation ,Ethical Research ,Cancer ,Chip ,Immunity ,Kidney ,Antibodies ,Ntibody ,Ntigen ,Bispecific Antibody ,Flood ,Fell ,Children ,Compound ,Drugs ,Wood ,Hospital ,Immune System ,Immunotherapy ,N Vitro ,N Vivo ,Liver ,Medical School ,Olecule ,Rganoids ,Mh ,Reclinical ,Protein ,Research ,Technology ,Humor ,Wilms Tumor ,